In Vivo Effects of Sulforaphane Supplementation on Normal Human Prostate
Interventional
Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Double Blind (Subject, Investigator, Outcomes Assessor), Primary Purpose: Prevention
Gene expression of Phase II enzymes
Change in Phase II enzyme expression
Baseline and 5 weeks
No
Daniel W Lin, MD
Principal Investigator
Fred Hutchinson Cancer Research Center
United States: Food and Drug Administration
PHS 2333.00
NCT00946309
July 2010
September 2016
Name | Location |
---|---|
VA Puget Sound | Seattle, Washington 98108 |